As one example, CTLA-4-immunoglobulin (CTLA-4–Ig) can alter the functional phenotype of immunogenic dendritic cells in experimental type-1 diabetes by modulating tryptophan catabolism. This evidence concerns the gene CTLA4 and type 1 diabetes mellitus.